Abstract
Introduction: depression and anxiety are the most common mental disorders, with a significant prevalence in the general population, increasing after the COVID-19 pandemic. Mindfulness and Self-Compassion have been shown to improve emotional well-being, reduce symptoms of anxiety and stress, and increase overall well-being. However, the impact of group programs involving these interventions in mental health settings and clinical populations requires further exploration.Methods: a quantitative study was designed with a prospective approach in a sample of 24 subjects with a diagnosis of depression or anxiety. A non-standardized group program based on Mindfulness and Self-Compassion was applied for eight weeks. Participants completed the Self-Compassion scale and the Pemberton Index before and after the intervention.Results: the results indicate that the intervention had a significant positive impact on the participants. The dimensions associated with Self-compassion and Non-Compassionate Aspects presented statistically significant changes. Self-Compassion improved significantly, while Mindfulness showed no change. Subjective Well-being also improved significantly in all its dimensions.Conclusions: the group intervention based on Mindfulness and Self-compassion had a significant positive impact on the participants. The results suggest that Self-Compassion practices may be more effective in promoting emotional well-being than those focused exclusively on Mindfulness, especially in the clinical setting. These findings are consistent with existing literature and raise an interesting debate about the clinical relevance of Self-Compassion alone compared to Mindfulness
Publisher
Salud, Ciencia y Tecnologia
Reference25 articles.
1. 1. World Health Organization. Depressive disorder (depression) [Internet]. Geneva: WHO; 2023 March 31 [citado 2024 Jun 5]. Available from: https://www.who.int/news-room/fact-sheets/detail/depression
2. 2. Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, et al. Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States. Psiquiatría JAMA. 2018 Apr 1;75(4):336-346. DOI:10.1001/jamapsychiatry.2017.4602.
3. 3. World Health Organization. COVID-19 pandemic triggers 25 % increase in prevalence of anxiety and depression worldwide. Wake-up call to all countries to step up mental health services and support [News release]. Ginebra: WHO; 2022 March 2 [citado 2024 Jun 5]. Available from: https://www.who.int/news/item/02-03-2022-covid-19-pandemic-triggers-25-increase-in-prevalence-of-anxiety-and-depression-worldwide
4. 4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Publishing; 2013. DOI:10.1176/appi.books.9780890425596
5. 5. Subdirección General de Información Sanitaria. Salud mental en datos: prevalencia de los problemas de salud y consumo de psicofármacos y fármacos relacionados a partir de registros clínicos de atención primaria. BDCAP Series 2. [Publicación en Internet]. Madrid: Ministerio de Sanidad. 2021 [citado 2024 Jun 5]. Disponible en: https://www.sanidad.gob.es/estadEstudios/estadisticas/estadisticas/estMinisterio/SIAP/Salud_mental_datos.pdf